Trulieve Cannabis Corp.
TRLV
$12.11
$0.121.00%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.90% | -1.39% | -0.45% | 1.44% | 1.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.90% | -1.39% | -0.45% | 1.44% | 1.89% |
| Cost of Revenue | 0.62% | 2.32% | -0.15% | -4.81% | -10.21% |
| Gross Profit | -6.76% | -3.75% | -0.65% | 5.92% | 11.37% |
| SG&A Expenses | -17.94% | -18.30% | -12.78% | 6.25% | 33.60% |
| Depreciation & Amortization | -1.22% | 3.19% | 4.26% | 4.93% | 5.22% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.45% | -7.45% | -5.59% | 0.95% | 8.47% |
| Operating Income | 55.49% | 79.33% | 60.33% | 5.64% | -43.15% |
| Income Before Tax | -1,073.29% | 209.78% | 114.06% | 17.37% | -63.20% |
| Income Tax Expenses | -28.38% | -8.79% | 5.33% | 6.32% | 9.44% |
| Earnings from Continuing Operations | -179.13% | 50.35% | 24.66% | -0.88% | -79.98% |
| Earnings from Discontinued Operations | -16.89% | 15.82% | 2.39% | -187.68% | -13.47% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -56.94% | 11.10% | 7.26% | 37.44% | 71.93% |
| Net Income | -184.01% | 50.81% | 24.96% | -3.51% | -77.42% |
| EBIT | 55.49% | 79.33% | 60.33% | 5.64% | -43.15% |
| EBITDA | 18.31% | 28.39% | 24.25% | 4.46% | -18.99% |
| EPS Basic | -193.10% | 51.09% | 25.47% | 10.22% | -57.41% |
| Normalized Basic EPS | -873.16% | 198.99% | 130.66% | 20.04% | -56.03% |
| EPS Diluted | -193.10% | 51.09% | 25.47% | 10.22% | -57.41% |
| Normalized Diluted EPS | -873.16% | 198.99% | 130.66% | 20.04% | -56.03% |
| Average Basic Shares Outstanding | 0.75% | 0.67% | 0.70% | 0.61% | 0.63% |
| Average Diluted Shares Outstanding | 0.75% | 0.67% | 0.70% | 0.61% | 0.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |